There have been many advancements in terms of treatment and imaging modalities for patients with oligometastatic prostate cancer. Failure to understand these advancements in treatment options leads to lower quality of care delivered by clinicians treating prostate cancer patients.
Radiation and immunotherapies are commonly utilized sequentially or concurrently for the treatment of cancer patients, yet we are still developing our understanding of the optimal approaches for safely and effectively integrating these treatments.
This contouring activity focuses on primary and secondary brain tumors, including the planning/treatment of craniospinal irradiation (CSI) I for leptomeningeal disease, brain stereotactic radiosurgery (SRS) for intact and post operative brain metastases, and the treatment of glioma with a brief d
MRI-guided Radiation Therapy (MRgRT), FLASH proton therapy, concurrent immunotherapy, and radiation therapy and SBRT for oligometastatic disease, are emerging technologies and approaches to optimize cancer care.
Miscellaneous and Future Applications of Radiopharmaceutical Therapy – How To Become an Authorized User, Meta-iodobenzylguanidine, Rhenium Skin Cancer Therapy, Radiosynoviorthesis, Alpha Emitters, Other
This series provides an overview of historical and contemporary indications for radiation therapy in the treatment of nononcological conditions such as ventricular tachycardia, plantar fasciitis, Dupuytren's and Ledderhose diseases, osteoarthritis, and functional brain disorders.